ESWI WEBINARS: Preparing for COVID-19, RSV DISEASE and INFLUENZA concomitant outbreaks
Series of 5 free webinars.
FLU AND COVID-19 BOOSTER VACCINATIONS: WHERE DO WE GO?
INFLUENZA DIABETES COMMUNITY
Webinar
WHAT ABOUT RESPIRATORY VIRUS INFECTIONS?
PREVENTION FOR PEOPLE LIVING WITH DIABETES IN COVID TIMES
ESWI TV
Influenza movies, lectures, animated videos and ESWI streaming services
ESWI SUPPORT TO YOUNG SCIENTISTS
ESWI NEWS
ESWI GALLERY
ESWI TWITTER FEED
Monday, December 6th, 2021 at 3:13pm
#ESWI2021 is hosting a GREAT discussion on #EquitableAccess with an AMAZING panel, including Partnership for African Vaccine Manufacturing #Equity #Execution #COVID19 #COVAX @lwazimanzi @_AfricanUnion @AUC_MoussaFaki @DrBGellin @RockefellerFdn @CDCgov @gavi https://t.co/skJ3unlpIl
#ESWI2021 is hosting a GREAT discussion on #EquitableAccess with an AMAZING panel, including Partnership for African Vaccine Manufacturing #Equity #Execution #COVID19 #COVAX @lwazimanzi @_AfricanUnion @AUC_MoussaFaki @DrBGellin @RockefellerFdn @CDCgov @gavi https://t.co/skJ3unlpIl
Monday, December 6th, 2021 at 2:00pm
@florian_krammer will chair SCS12 "Structure-guided immunogen design that harnesses CD4 T cell memory from seasonal influenza increases vaccine-induced protection against H7N9 #influenza" @gen2vax Live now and tomorrow #ESWIViralTimes I #ESWI2021
https://t.co/aSZlqGWUxL
@florian_krammer will chair SCS12 "Structure-guided immunogen design that harnesses CD4 T cell memory from seasonal influenza increases vaccine-induced protection against H7N9 #influenza" @gen2vax Live now and tomorrow #ESWIViralTimes I #ESWI2021
https://t.co/aSZlqGWUxL
Monday, December 6th, 2021 at 1:45pm
#COVID19 patient study: "Safety, tolerability and pharmacokinetics of ensovibep in patients with mild to moderate #COVID19 - preliminary report of a phase 2a, open-label, single dose escalation study” @CHDR_NL @MolecularPrtnrs @LUMC_Leiden Today at 18h00 CET I SCS10 #ESWI2021
#COVID19 patient study: "Safety, tolerability and pharmacokinetics of ensovibep in patients with mild to moderate #COVID19 - preliminary report of a phase 2a, open-label, single dose escalation study” @CHDR_NL @MolecularPrtnrs @LUMC_Leiden Today at 18h00 CET I SCS10 #ESWI2021
Monday, December 6th, 2021 at 1:31pm
#COVID19 has opened eyes to the existential threat of #influenza. @rvenkayya hopes to see greater investments to fight flu as the ongoing #Pandemic allows “cutting edge science to look at influenza and helps us tackle seasonal flu”. @sabinvaccine #FightFlu I #ESWI2021
#COVID19 has opened eyes to the existential threat of #influenza. @rvenkayya hopes to see greater investments to fight flu as the ongoing #Pandemic allows “cutting edge science to look at influenza and helps us tackle seasonal flu”. @sabinvaccine #FightFlu I #ESWI2021
Monday, December 6th, 2021 at 12:59pm
Cherry Kang from @wellcometrust warns that it could take up to 20 years for #vaccines to reach the global south population due to the #equity gap between the high, middle and low income countries @sabinvaccine #FightFlu I #ESWI2021
Cherry Kang from @wellcometrust warns that it could take up to 20 years for #vaccines to reach the global south population due to the #equity gap between the high, middle and low income countries @sabinvaccine #FightFlu I #ESWI2021
Monday, December 6th, 2021 at 12:39pm
@sabinvaccine gathers stakeholders of the 10-year framework for improving the production&effectiveness of strain-specific seasonal #influenza vaccines and advancing the development, licensure & manufacture of durable, broadly protective or universal influenza vaccines #ESWI2021 https://t.co/gbBx9CfJnU
@sabinvaccine gathers stakeholders of the 10-year framework for improving the production&effectiveness of strain-specific seasonal #influenza vaccines and advancing the development, licensure & manufacture of durable, broadly protective or universal influenza vaccines #ESWI2021 https://t.co/gbBx9CfJnU
Monday, December 6th, 2021 at 11:08am
Join the LIVE roundtable discussion @Roche with the experts Frederick Hayden, Zain Chagla and and Alex Soriano to get an update on the latest clinical efficacy and safety data for neutralising monoclonal #antibodies I #ESWI2021
Join the LIVE roundtable discussion @Roche with the experts Frederick Hayden, Zain Chagla and and Alex Soriano to get an update on the latest clinical efficacy and safety data for neutralising monoclonal #antibodies I #ESWI2021
Monday, December 6th, 2021 at 11:04am
Alex Soriano @hospitalclinic explained during @Roche symposium that administering monoclonal #antibodies and #antivirals to #vaccinated patients reduces the viral load after 5 days adding a layer of protection against hospitalisation and severe symptoms from #COVID19 #ESWI2021 https://t.co/cs5OJOnbNP
Alex Soriano @hospitalclinic explained during @Roche symposium that administering monoclonal #antibodies and #antivirals to #vaccinated patients reduces the viral load after 5 days adding a layer of protection against hospitalisation and severe symptoms from #COVID19 #ESWI2021 https://t.co/cs5OJOnbNP
Monday, December 6th, 2021 at 10:33am
Zain Chagla @zchagla: “Monoclonal #antibodies and direct-acting #antivirals could play a key role for the management of #COVID19” symposium by @Roche I Day3 #ESWI2021 https://t.co/WEiae2rDuo
Zain Chagla @zchagla: “Monoclonal #antibodies and direct-acting #antivirals could play a key role for the management of #COVID19” symposium by @Roche I Day3 #ESWI2021 https://t.co/WEiae2rDuo
Monday, December 6th, 2021 at 9:00am
"Intranasal administration of TLR3-agonist Ampligen has potential as prophylaxis or early treatment for respiratory viral infections. Repeated administration up to 1250µg was well tolerated" @CHDR_NL @AimImmuno I SCS11 running until 13h45 #ESWI2021
"Intranasal administration of TLR3-agonist Ampligen has potential as prophylaxis or early treatment for respiratory viral infections. Repeated administration up to 1250µg was well tolerated" @CHDR_NL @AimImmuno I SCS11 running until 13h45 #ESWI2021
Monday, December 6th, 2021 at 8:30am
SCS09 ongoing: "Silencing pulmonary sensory neurons changes pathogenesis of IAV pulmonary infection, increasing clinical symptoms and pulmonary cytokine levels” @NathalieVerzele @Dr_AE_McGovern @K_RenfreeShort I #ESWI2021 https://t.co/bqXA04YeLX
SCS09 ongoing: "Silencing pulmonary sensory neurons changes pathogenesis of IAV pulmonary infection, increasing clinical symptoms and pulmonary cytokine levels” @NathalieVerzele @Dr_AE_McGovern @K_RenfreeShort I #ESWI2021 https://t.co/bqXA04YeLX
Monday, December 6th, 2021 at 8:25am
LIVE from the studio! Poster Peek with @goeijenbier I Day3 #ESWI2021 https://t.co/z2FXI9VFGv
LIVE from the studio! Poster Peek with @goeijenbier I Day3 #ESWI2021 https://t.co/z2FXI9VFGv
Monday, December 6th, 2021 at 7:04am
"Neuropilin-1 may provide the selective pressure for highly pathogenic avian influenza virus genesis from low pathogenic avian influenza viral variants in chickens” @LSteele44 @K_RenfreeShort. More details tomorrow #ESWIViralTimes I Day3 #ESWI2021
https://t.co/aSZlqGWUxL
"Neuropilin-1 may provide the selective pressure for highly pathogenic avian influenza virus genesis from low pathogenic avian influenza viral variants in chickens” @LSteele44 @K_RenfreeShort. More details tomorrow #ESWIViralTimes I Day3 #ESWI2021
https://t.co/aSZlqGWUxL
Monday, December 6th, 2021 at 6:45am
Happening now @SCS07 Lessons learned and prospects for #COVID19 vaccination! Novavax Vaccine Clinical Development Program."Limited data exist on pregnancy outcomes in #COVID19 vaccines clinical trials", by Hadi Beyhaghi I #ESWI2021 Follow the session ⬇️☕️
https://t.co/jj7K7dIv5k
Happening now @SCS07 Lessons learned and prospects for #COVID19 vaccination! Novavax Vaccine Clinical Development Program."Limited data exist on pregnancy outcomes in #COVID19 vaccines clinical trials", by Hadi Beyhaghi I #ESWI2021 Follow the session ⬇️☕️
https://t.co/jj7K7dIv5k
Monday, December 6th, 2021 at 5:54am
Hi @cggbamford. All the ESWI team at the studio is implementing very strict safety measures according to the ESWI #COVID19 contingency plan, which includes daily self-test and Covid safe scan, as well as wearing masks by all the crew who is not at the stage. https://t.co/Dr5xSnA4cr
Hi @cggbamford. All the ESWI team at the studio is implementing very strict safety measures according to the ESWI #COVID19 contingency plan, which includes daily self-test and Covid safe scan, as well as wearing masks by all the crew who is not at the stage. https://t.co/Dr5xSnA4cr
Monday, December 6th, 2021 at 5:51am
@cggbamford Hi @cggbamford. All the ESWI team at the studio is implementing a very strict safety measures according to the #COVID19 contingency plan, which includes daily self-test and Covid-Safe scan, as well as wearing masks by all the crew who is not at the stage 🙂
@cggbamford Hi @cggbamford. All the ESWI team at the studio is implementing a very strict safety measures according to the #COVID19 contingency plan, which includes daily self-test and Covid-Safe scan, as well as wearing masks by all the crew who is not at the stage 🙂
Monday, December 6th, 2021 at 5:49am
@cggbamford Hi @cggbamford. All the ESWI team at the studio is implementing very strict safety measures according to the #COVID19 contingency plan, which includes daily self-test and Covid-Safe scan, as well as wearing masks by all the crew who is not at the stage 🙂
@cggbamford Hi @cggbamford. All the ESWI team at the studio is implementing very strict safety measures according to the #COVID19 contingency plan, which includes daily self-test and Covid-Safe scan, as well as wearing masks by all the crew who is not at the stage 🙂
